Hugh Crawford

ANU Connect Ventures Pty Ltd (ANU Connect Ventures) is a venture capital subsidiary of Australian National University founded in 2005. The firm is headquartered in Canberra, Australia.

Dosimetry & Imaging Pty Ltd. develops X-ray storage phosphor for use in radiation detection and medical imaging. The firm specializes in detecting radiation exposure for use in personal dosimetry, homeland security and medical therapeutic products and measures life time exposure and reduces an individual’s exposure. The company was founded by Hans Riesen in 2007 and is headquartered in Sydney, Australia.

Savine Therapeutics Pty Ltd. develops vaccines for infectious diseases. The company was founded by Scott Anthony Thomson and Ian Alistair Ramshaw and is headquartered in Canberra, Australia.

GPN Vaccines Ltd. is an Australian biotechnology company that is developing a vaccine called Gamma-PN™ to protect against all strains of Streptococcus pneumoniae, which causes life-threatening pneumonia, bacteremia, meningitis, and middle ear infections. The company is based in Adelaide, Australia, and Tim Hirst has been the CEO since 2017. This disease is responsible for causing 1-2 million deaths worldwide each year, particularly in children.